PROK stock icon

ProKidney

2.00 USD
+0.07
3.63%
At close Nov 8, 4:00 PM EST
1 day
3.63%
5 days
29.87%
1 month
15.61%
3 months
-4.31%
6 months
-17.36%
Year to date
16.96%
1 year
19.05%
5 years
-76.83%
 

About: ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's own cells isolated from the patient intended for treatment. Its lead product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's own renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of development program for severe diabetic kidney disease.

Employees: 163

0
Funds holding %
of 6,759 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)

290% more call options, than puts

Call options by funds: $1.18M | Put options by funds: $303K

143% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 7

86% more repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 14

72% more capital invested

Capital invested by funds: $78M [Q1] → $134M (+$56.3M) [Q2]

18% more funds holding

Funds holding: 55 [Q1] → 65 (+10) [Q2]

0% more funds holding in top 10

Funds holding in top 10: 1 [Q1] → 1 (+0) [Q2]

24.38% less ownership

Funds ownership: 70.77% [Q1] → 46.39% (-24.38%) [Q2]

Research analyst outlook

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$3
50%
upside
Avg. target
$4.50
125%
upside
High target
$6
200%
upside

2 analyst ratings

positive
50%
neutral
50%
negative
0%
Guggenheim
Vamil Divan
75% 1-year accuracy
12 / 16 met price target
200%upside
$6
Buy
Initiated
10 Sept 2024
B of A Securities
Jason Gerberry
44% 1-year accuracy
11 / 25 met price target
50%upside
$3
Neutral
Maintained
4 Sept 2024

Financial journalist opinion

Charts implemented using Lightweight Charts™